Caricamento...
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica
OBJECTIVE: To minimize complement-mediated damage in acute relapses of neuromyelitis optica (NMO) by adding treatment with a complement inhibitor, purified C1-esterase inhibitor, to the current standard of care (high-dose glucocorticoids). METHOD: We conducted an open-label phase 1b safety and proof...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Lippincott Williams & Wilkins
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4202676/ https://ncbi.nlm.nih.gov/pubmed/25340061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000005 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|